About this medicine
Canmab 440 Mg Injection
Canmab 440 mg Injection is an injectable solution used to treat specific forms of cancer. It is a monoclonal antibody that aids the immune system in its battle against cancer cells. It is administered by a healthcare practitioner for the treatment of metastatic breast cancer and non-small cell lung cancer. It is available in prefilled syringes and can be administered subcutaneously, intramuscularly, or intravenously. Before beginning this treatment, patients should consider the risks and advantages of it with their healthcare professional. Canmab 440 mg Injection side effects include fever, chills, nausea, weariness, and body pains. Among the more significant adverse effects include breathing difficulties, chest discomfort, and allergic responses. It is essential to adhere to your healthcare provider's recommendations and take all drugs as recommended. This can aid in achieving the greatest potential results from this drug.
|
Name |
Canmab 440 mg Injection |
|
Salt |
Trastuzumab (440mg) |
|
Manufactured By |
Biocon |
|
Packaging |
Vial |
|
Use |
Anti cancer medicine |
